The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Abstract
CONTEXT: Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described. OBJECTIVE: To estimate prevalence of atrial fibrillation and US national projections of the numbers of persons with atrial fibrillation through the year 2050. DESIGN, SETTING, AND PATIENTS: Cross-sectional study of adults aged 20 years or older who were enrolled in a large health maintenance organization in California and who had atrial fibrillation diagnosed between July 1, 1996, and December 31, 1997. MAIN OUTCOME MEASURES: Prevalence of atrial fibrillation in the study population of 1.89 million; projected number of persons in the United States with atrial fibrillation between 1995-2050. RESULTS: A total of 17 974 adults with diagnosed atrial fibrillation were identified during the study period; 45% were aged 75 years or older. The prevalence of atrial fibrillation was 0.95% (95% confidence interval, 0.94%-0.96%). Atrial fibrillation was more common in men than in women (1.1% vs 0.8%; P<.001). Prevalence increased from 0.1% among adults younger than 55 years to 9.0% in persons aged 80 years or older. Among persons aged 50 years or older, prevalence of atrial fibrillation was higher in whites than in blacks (2.2% vs 1.5%; P<.001). We estimate approximately 2.3 million US adults currently have atrial fibrillation. We project that this will increase to more than 5.6 million (lower bound, 5.0; upper bound, 6.3) by the year 2050, with more than 50% of affected individuals aged 80 years or older. CONCLUSIONS: Our study confirms that atrial fibrillation is common among older adults and provides a contemporary basis for estimates of prevalence in the United States. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Coordinated efforts are needed to face the increasing challenge of optimal stroke prevention and rhythm management in patients with atrial fibrillation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States, it is estimated that the number of adults with AF would more than double by the year 2050;16 even higher increases have been predicted.14”
From Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study (2014) · cites this paper as [16]
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 9,034
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,756
Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.13.1449 · Cited by 2,602
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,282
Incidence of and risk factors for atrial fibrillation in older adults
Psaty, B. M., Manolio, T. A., Kuller, L. H., Kronmal, R. A., Cushman, M., Fried, L. P., White, R., Furberg, C. D., & Rautaharju, P. M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2455 · Cited by 1,462
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90363-8 · Cited by 1,096
Page, R. L., Wilkinson, W. E., Clair, W. K., McCarthy, E. A., & Pritchett, E. L. (1994) · Circulation · doi:10.1161/01.cir.89.1.224 · Cited by 627
Cited by
Sorted by citations
Items 301–400 of 1,022
Carlo, A. D., Bellino, L., Consoli, D., Mori, F., Zaninelli, A., Baldereschi, M., Cattarinussi, A., D’Alfonso, M. G., Gradia, C., Sgherzi, B., et al. (2019) · EP Europace · doi:10.1093/europace/euz141 · Cited by 196
Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial
Goette, A., Schön, N., Kirchhof, P., Breithardt, G., Fetsch, T., Häusler, K. G., Klein, H. U., Steinbeck, G., Wegscheider, K., & Meinertz, T. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.965178 · Cited by 187
Prevalence of Atrial Fibrillation in Spain. OFRECE Study Results
Gómez‐Doblas, J. J., Muñiz, J., Martin, J. J. A., Rodríguez-Roca, G., Lobos, J. M., García, P. A., Permanyer-Miralda, G., Chorro, F. J., Anguita, M. P., & Roig, E. S. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.07.014 · Cited by 187
Choudhry, N. K., Anderson, G., Laupacis, A., Ross‐Degnan, D., Normand, S. T., & Soumerai, S. B. (2006) · BMJ · doi:10.1136/bmj.38698.709572.55 · Cited by 184
Friedman, D. J., Piccini, J. P., Wang, T., Zheng, J., Malaisrie, S. C., Holmes, D. R., Suri, R. M., Mack, M. J., Badhwar, V., Jacobs, J. P., et al. (2018) · JAMA · doi:10.1001/jama.2017.20125 · Cited by 187
Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
Fang, M. C., Go, A. S., Chang, Y., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N. V., & Singer, D. E. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.937680 · Cited by 185
Self-citationIndependent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation
Nichols, G. A., Reinier, K., & Chugh, S. S. (2009) · Diabetes Care · doi:10.2337/dc09-0939 · Cited by 181
Cardiac Disease in Chronic Obstructive Pulmonary Disease
Falk, J., Kadiev, S., Criner, G. J., Scharf, S. M., Minai, O. A., & Diaz, P. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-142et · Cited by 185
A Novel Method for Detection of the Transition Between Atrial Fibrillation and Sinus Rhythm
Huang, C. H., Ye, S., Chen, H., Li, D., He, F., & Tu, Y. (2010) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2010.2096506 · Cited by 183
Qureshi, W., Nasir, U., Alqalyoobi, S., O’Neal, W. T., Mawri, S., Sabbagh, S., Soliman, E. Z., & Al-Mallah, M. H. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.08.046 · Cited by 184
Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections
Stefansdottir, H., Aspelund, T., Gudnason, V. G., & Arnar, D. O. (2011) · EP Europace · doi:10.1093/europace/eur132 · Cited by 187
New oral anticoagulants in atrial fibrillation
Turpie, A. G. G. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm575 · Cited by 182
Complications arising from catheter ablation of atrial fibrillation: Temporal trends and predictors
Hoyt, H., Bhonsale, A., Chilukuri, K., Alhumaid, F., Needleman, M., Edwards, D., Govil, A., Nazarian, S., Cheng, A., Henrikson, C. A., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.07.025 · Cited by 181
Boriani, G., Savelieva, I., Dan, G., Deharo, J., Ferro, C. J., Israel, C. W., Lane, D. A., Manna, G. L., Morton, J. B., Moya‐Mitjans, À., et al. (2015) · EP Europace · doi:10.1093/europace/euv202 · Cited by 187
Cardiac sodium channel mutation in atrial fibrillation
Ellinor, P. T., Nam, E. G., Shea, M. A., Milan, D. J., Ruskin, J. N., & MacRae, C. A. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.09.015 · Cited by 180
Causes of Death and Influencing Factors in Patients with Atrial Fibrillation
Fauchier, L., Villejoubert, O., Clémenty, N., Bernard, A. B., Pierre, B., Angoulvant, D., Ivanés, F., Babuty, D., & Lip, G. Y. H. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.06.045 · Cited by 179
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes
Echouffo-Tcheugui, J. B., Shrader, P. J., Thomas, L. E., Gersh, B. J., Kowey, P. R., Mahaffey, K. W., Singer, D. E., Hylek, E. M., Go, A. S., Peterson, E. D., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.755 · Cited by 180
Self-citationEstimated prevalence of undiagnosed atrial fibrillation in the United States
Turakhia, M. P., Shafrin, J. T., Bognar, K., Trocio, J. N., Abdulsattar, Y., Wiederkehr, D., & Goldman, D. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195088 · Cited by 180
Aune, D., Schlesinger, S., Norat, T., & Ríboli, E. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318780435 · Cited by 184
Prevalence of early-onset atrial fibrillation in congenital long QT syndrome
Johnson, J. N., Tester, D. J., Perry, J., Salisbury, B. A., Reed, C. R., & Ackerman, M. J. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.02.007 · Cited by 179
Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation: A Systematic Review
Al-Khatib, S. M., Allen LaPointe, N. M., Chatterjee, R., Crowley, M. J., Dupre, M. E., Kong, D. F., Lopes, R. D., Povsic, T. J., Raju, S. S., Shah, B., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1467 · Cited by 178
Haywood, L. J., Ford, C. E., Crow, R. S., Davis, B. R., Massie, B. M., Einhorn, P. T., & Williard, A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.020 · Cited by 180
Atrial Cardiopathy: A Broadened Concept of Left Atrial Thromboembolism Beyond Atrial Fibrillation
Kamel, H., Okin, P. M., Longstreth, W. T., Elkind, M. S. V., & Soliman, E. Z. (2015) · Future Cardiology · doi:10.2217/fca.15.22 · Cited by 175
Corticosteroids and the Risk of Atrial Fibrillation
van der Hooft, C. S., Heeringa, J., Brusselle, G., Albert Hofman, D., Witteman, J. C. M., Kingma, J. H., Sturkenboom, M., & Stricker, B. H. C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.9.1016 · Cited by 175
Soliman, E. Z., Lopez, F., O’Neal, W. T., Chen, L. Y., Bengtson, L., Zhang, Z.-M., Loehr, L., Cushman, M., & Alonso, A. (2015) · Circulation · doi:10.1161/circulationaha.114.014145 · Cited by 174
An Update on the Prognosis of Patients With Atrial Fibrillation
McManus, D. D., Rienstra, M., & Benjamin, E. J. (2012) · Circulation · doi:10.1161/circulationaha.112.129759 · Cited by 178
Conen, D., Ridker, P. M., Everett, B. M., Tedrow, U. B., Rose, L. M., Cook, N. R., Buring, J. E., & Albert, C. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq146 · Cited by 177
Increased Atrial Fibrillation Mortality: United States, 1980-1998
Wattigney, W. A. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.9.819 · Cited by 176
Long‐Term Clinical Efficacy and Risk of Catheter Ablation for Atrial Fibrillation in the Elderly
Zado, E. S., Callans, D. J., RILEY, M., Hutchinson, M. D., Garcia, F. C., Bala, R., Lin, D., Cooper, J. M., Verdino, R. J., Russo, A. M., et al. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01183.x · Cited by 175
Clinical Validation of 5 Direct-to-Consumer Wearable Smart Devices to Detect Atrial Fibrillation
Mannhart, D., Lischer, M., Knecht, S., du Fay de Lavallaz, J., Strebel, I., Serban, T., Vögeli, D., Schaer, B., Osswald, S., Mueller, C., et al. (2023) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2022.09.011 · Cited by 175
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W. A., Wildgoose, P., van Eickels, M., Lip, G. Y. H., Cohen, M. C., Husted, S., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.12.006 · Cited by 180
Baril, D. T., Ghosh, K., & Rosen, A. B. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.03.244 · Cited by 174
Bayard, Y. L., Omran, H., Neužil, P., Thuesen, L., Pichler, M., Rowland, E., Ramondo, A. B., Rużyłło, W., Budts, W., Montalescot, G., et al. (2010) · EuroIntervention · doi:10.4244/eijv6i2a35 · Cited by 175
Epidemiology of Peripartum Cardiomyopathy
Gunderson, E. P., Croen, L., Chiang, V., Yoshida, C. K., WALTON, D. L., & Go, A. S. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318229e6de · Cited by 175
Self-citationChen, L. Y., Norby, F. L., Gottesman, R. F., Mosley, T. H., Soliman, E. Z., Agarwal, S. K., Loehr, L. R., Folsom, A. R., Coresh, J., & Alonso, Á. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007301 · Cited by 181
Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
Aboumsallem, J. P., Moslehi, J. J., & de Boer, R. A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013754 · Cited by 178
Paradigm of Genetic Mosaicism and Lone Atrial Fibrillation
Thibodeau, I., Xu, J., Li, Q., Liu, G., Lam, K., Veinot, J. P., BIRNIE, D. H., Jones, D. L., Krahn, A. D., Lemery, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.961227 · Cited by 172
Khan, A. A., Lip, G. Y. H., & Shantsila, A. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13174 · Cited by 172
Ferrara, A., Hedderson, M. M., Brown, S. D., Albright, C. L., Ehrlich, S. F., Tsai, A.-L., Caan, B. J., Sternfeld, B., Gordon, N. P., Schmittdiel, J. A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1254 · Cited by 171
Desteghe, L., Raymaekers, Z., Lutin, M., Vijgen, J. M., Dilling-Boer, D. M., Koopman, P., Schurmans, J., Vanduynhoven, P., Dendale, P., & Heidbüchel, H. (2016) · EP Europace · doi:10.1093/europace/euw025 · Cited by 171
Tarantini, G., Mojoli, M., Ureña, M., & Vahanian, A. S. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw456 · Cited by 171
Arrhythmias in Patients ≥80 Years of Age
Curtis, A. B., Karki, R., Hattoum, A., & Sharma, U. C. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.019 · Cited by 180
Yiin, G. S. C., Howard, D. P. J., Paul, N. L. M., Li, L., Luengo-Fernández, R., Bull, L. M., Welch, S. J. V., Gutnikov, S. A., Mehta, Z., & Rothwell, P. M. (2014) · Circulation · doi:10.1161/circulationaha.114.010942 · Cited by 169
Rich, D. Q., Mittleman, M. A., Link, M. S., Schwartz, J. D., Luttmann‐Gibson, H., Catalano, P. J., Speizer, F. E., Gold, D. R., & Dockery, D. W. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8371 · Cited by 167
Aune, D., Sen, A., Schlesinger, S., Norat, T., Janszky, I., Romundstad, P., Tonstad, S., Ríboli, E., & VATTEN, L. J. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0232-4 · Cited by 177
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
Lip, G. Y. H., Proietti, M., Potpara, T., MANSOUR, M. C., Savelieva, I., Tse, H., Goette, A., Camm, A. J., Blomström‐Lundqvist, C., Gupta, D., et al. (2023) · EP Europace · doi:10.1093/europace/euad226 · Cited by 176
Pacientes con fibrilación auricular asistidos en consultas de atención primaria. Estudio Val-FAAP
Barrios, V., Calderón, A., Escobar, C., & de la Figuera, M. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.08.008 · Cited by 166
Ananthapanyasut, W., Napan, S., Rudolph, E. H., Harindhanavudhi, T., Ayash, H., Guglielmi, K. E., & Lerma, E. V. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03170509 · Cited by 168
Kim, Y. Y., Klein, A. L., Halliburton, S. S., Popović, Z., Kuzmiak, S. A., Sola, S., Garcia, M. J., Schoenhagen, P., Natale, A., & Desai, M. Y. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.08.004 · Cited by 164
Premature Atrial Contractions in the General Population
Conen, D., Adam, M., Roche, F., Barthélemy, J., Dietrich, D. F., Imboden, M., Künzli, N., von Eckardstein, A., Regenass, S., Hornemann, T., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.112300 · Cited by 174
Natural History and Long-Term Outcomes of Ablated Atrial Fibrillation
Hussein, A. A., Saliba, W. I., Martin, D. O., Bhargava, M., Sherman, M., Magnelli-Reyes, C., Chamsi‐Pasha, M. A., John, S., Williams‐Andrews, M., Baranowski, B. J., et al. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962100 · Cited by 165
Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality
Magnani, J. W., Norby, F. L., Agarwal, S. K., Soliman, E. Z., Chen, L. Y., Loehr, L. R., & Alonso, Á. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1025 · Cited by 166
Lee, S., Choi, E., Han, K., Cha, M., & Oh, S. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.039 · Cited by 165
Screening for Atrial Fibrillation With Electrocardiography
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.10321 · Cited by 165
Reiffel, J. A., Camm, A. J., Belardinelli, L., Zeng, D., Karwatowska‐Prokopczuk, E., Olmsted, A., Zaręba, W., Rosero, S. Z., & Kowey, P. R. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.002856 · Cited by 164
Screening for Atrial Fibrillation
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M. D., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Epling, J. W., et al. (2022) · JAMA · doi:10.1001/jama.2021.23732 · Cited by 169
Huxley, R. R., Misialek, J. R., Agarwal, S. K., Loehr, L. R., Soliman, E. Z., Chen, L. Y., & Alonso, A. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001244 · Cited by 169
McDonald, A. J., Pelletier, A. J., Ellinor, P. T., & Camargo, C. A. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.03.007 · Cited by 161
Alcohol Abuse and Cardiac Disease
Whitman, I. R., Agarwal, V., Nah, G., Dukes, J. W., Vittinghoff, E., Dewland, T. A., & Marcus, G. M. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.048 · Cited by 164
Epidemiology of Arrhythmias and Sudden Cardiac Death in Asia
Murakoshi, N., & Aonuma, K. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-1129 · Cited by 167
Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation
Bhave, P. D., Lu, X., Girotra, S. R., Kamel, H., & Vaughan‐Sarrazin, M. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.031 · Cited by 162
Xiong, Q., Proietti, M., Senoo, K., & Lip, G. Y. H. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.011 · Cited by 161
Neilan, T. G., Farhad, H., Dodson, J. A., Shah, R. V., Abbasi, S. A., Bakker, J. P., Michaud, G. F., van der Geest, R., Blankstein, R., Steigner, M., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000421 · Cited by 158
Impact of Obesity on Cardiovascular Disease
Zalesin, K. C., Franklin, B. A., Miller, W. M., Peterson, E. D., & McCullough, P. A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.004 · Cited by 157
Prediction Rule for Atrial Fibrillation After Major Noncardiac Thoracic Surgery
PASSMAN, R. S., Gingold, D. B., Amar, D., Lloyd‐Jones, D. M., Bennett, C. L., Zhang, H., & Rusch, V. W. (2005) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.10.058 · Cited by 157
PULSE‐SMART: Pulse‐Based Arrhythmia Discrimination Using a Novel Smartphone Application
McMANUS, D. D., CHONG, J. W., SONI, A., SACZYNSKI, J. S., ESA, N., NAPOLITANO, C., DARLING, C. E., BOYER, E., ROSEN, R. K., FLOYD, K. C., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12842 · Cited by 156
Essien, U. R., Holmes, D. N., Jackson, L. R., Fonarow, G. C., Mahaffey, K. W., Reiffel, J. A., Steinberg, B. A., Allen, L. A., Chan, P. S., Freeman, J. V., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.3945 · Cited by 155
Self-citationFerri, N., Colombo, E., Tenconi, M., Baldessin, L., & Corsini, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061120 · Cited by 168
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation
Ansell, J., & Mantha, S. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-02-0093 · Cited by 154
Cardiac Magnetic Resonance–Measured Left Atrial Volume and Function and Incident Atrial Fibrillation
Habibi, M., Samiei, S., Ambale‐Venkatesh, B., Opdahl, A., Helle-Valle, T. M., Zareian, M., de Almeida, A. L. C., Choi, E., Wu, C. O., Alonso, Á., et al. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.004299 · Cited by 157
Ray, W. A., Chung, C. P., Stein, C. M., Smalley, W. E., Zimmerman, E. E., Dupont, W. D., Hung, A. M., Daugherty, J. R., Dickson, A. L., & Murray, K. T. (2021) · JAMA · doi:10.1001/jama.2021.21222 · Cited by 156
Olshansky, B., Heller, E. N., Mitchell, L. B., Chandler, M. L., Slater, W., Green, M. S., Brodsky, M. A., Barrell, P., & Greene, H. L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.020 · Cited by 155
Flint, A. C., Kamel, H., Navi, B. B., Rao, V. A., Faigeles, B. S., Conell, C. A., Klingman, J. G., Sidney, S., Hills, N. K., Sorel, M. E., et al. (2011) · Stroke · doi:10.1161/strokeaha.111.627729 · Cited by 153
Racial Disparities in Awareness and Treatment of Atrial Fibrillation
Meschia, J. F., Merrill, P., Soliman, E. Z., Howard, V. J., Barrett, K. M., Zakai, N. A., Kleindorfer, D., Safford, M. M., & Howard, G. (2010) · Stroke · doi:10.1161/strokeaha.109.573907 · Cited by 154
Christensen, H., Cordonnier, C., Kõrv, J., Lal, A., Ovesen, C., Purrucker, J. C., Toni, D., & Steiner, T. (2019) · European Stroke Journal · doi:10.1177/2396987319849763 · Cited by 162
Steinberg, B. A., Kim, S., Fonarow, G. C., Thomas, L., Ansell, J., Kowey, P. R., Mahaffey, K. W., Gersh, B. J., Hylek, E., Naccarelli, G., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.02.003 · Cited by 154
Self-citationMathew, J. S., Sachs, M. C., Katz, R., Patton, K. K., Heckbert, S. R., Hoofnagle, A. N., Alonso, A., Chonchol, M., Deo, R., Ix, J. H., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005499 · Cited by 153
2018 Korean Guideline of Atrial Fibrillation Management
Joung, B., Lee, J., Lee, K. H., Kim, T., Choi, E., Lim, W., Kang, K., Uhm, J., Lim, H. E., Park, J., et al. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0339 · Cited by 157
Risk of Atrial Fibrillation According to Cancer Type
Yun, J. P., Choi, E., Han, K., Park, S. H., Jung, J., Park, S. H., Ahn, H., Lim, J., Lee, S., & Oh, S. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.03.006 · Cited by 153
Blood Lipid Levels, Lipid-Lowering Medications, and the Incidence of Atrial Fibrillation
Norby, F. L., Agarwal, S. K., MacLehose, R. F., Soliman, E. Z., Sharrett, A. R., Huxley, R., Konety, S., Ballantyne, C. M., & Alonso, Á. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966804 · Cited by 155
Cooper, N. J., Sutton, A. J., Lu, G., & Khunti, K. K. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.12.1269 · Cited by 152
Cosío, F. G., Aliot, E., Botto, G., Heidbuchel, H., Geller, J. C., Kirchhof, P. F., Haro, J.-C. D., Frank, R., Pérez‐Villacastín, J., Vijgen, J. M., et al. (2007) · EP Europace · doi:10.1093/europace/eum276 · Cited by 153
Clarkesmith, D., Pattison, H. M., Khaing, P., & Lane, D. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008600.pub3 · Cited by 152
Stroke prevention in atrial fibrillation—An Asian stroke perspective
Tse, H., Wang, Y. J., Ai-Abdullah, M. A., Borromeo, A., Chiang, C., Krittayaphong, R., Singh, B. B., Vora, A. M., Wang, C., Zubaid, M., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.03.017 · Cited by 150
Gender-Specific Differences in Major Cardiac Events and Mortality in Lamin A/C Mutation Carriers
van Rijsingen, I. A. W., Nannenberg, E. A., Arbustini, E., Elliot, P. M., Mogensen, J., Ast, J. F. H.-V., van der Kooi, A. J., van Tintelen, J. P., van den Berg, M. P., Grasso, M., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs191 · Cited by 151
Zalesak, M., Siu, K., Francis, K. M., Chen, Y. X., Alvrtsyan, H., Rao, Y., Walker, D. R., Sander, S. D., Miyasato, G., Matchar, D. B., et al. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000192 · Cited by 151
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
Wong, J. A., Conen, D., Gelder, I. C. V., McIntyre, W. F., Crijns, H. J. G. M., Wang, J., Gold, M. R., Hohnloser, S. H., Lau, C., Capucci, A., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.519 · Cited by 152
Wearable Digital Health Technologies for Monitoring in Cardiovascular Medicine
Spatz, E. S., Ginsburg, G. S., Rumsfeld, J. S., & Turakhia, M. P. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2301903 · Cited by 166
Reynolds, M. R., ZIMETBAUM, P. J., Josephson, M. E., Ellis, E., Danilov, T., & Cohen, D. J. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.837294 · Cited by 149
Pisters, R., Nieuwlaat, R., Prins, M. H., Heuzey, J. Y. L., Maggioni, A. P., Camm, A. J., Crijns, H. J. G. M., & for the Euro Heart Survey Investigators (2012) · EP Europace · doi:10.1093/europace/eur406 · Cited by 152
Drug and dietary interactions of the new and emerging oral anticoagulants
Walenga, J. M., & Adıgüzel, C. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02286.x · Cited by 152
Atrial Fibrillation in Congestive Heart Failure
Lubitz, S. A., Benjamin, E. J., & Ellinor, P. T. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.11.001 · Cited by 151
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
O’Brien, C. L. (2005) · JAMA · doi:10.1001/jama.293.6.699 · Cited by 149
McNamara, R. L., Brass, L. M., Drozda, J. P., Go, A. S., Halperin, J. L., Kerr, C. R., Lévy, S., Malenka, D. J., Mittal, S., Pelosi, F., et al. (2004) · Circulation · doi:10.1161/01.cir.0000131893.41821.d1 · Cited by 149
Self-citationNyboe, C., Olsen, M. S., Nielsen‐Kudsk, J. E., & Hjortdal, V. E. (2015) · Heart · doi:10.1136/heartjnl-2014-306552 · Cited by 148
Freeman, J. V., Wang, Y., Akar, J. G., Desai, N. R., & Krumholz, H. M. (2017) · Circulation · doi:10.1161/circulationaha.116.022388 · Cited by 148
The Global Burden of Atrial Fibrillation and Stroke
Bai, Y., Wang, Y., Shantsila, A., & Lip, G. Y. H. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.03.048 · Cited by 150
Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus
Hedderson, M. M., Williams, M. A., Holt, V. L., Weiss, N. S., & Ferrara, A. M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.09.028 · Cited by 156
Pulmonary Toxicity in Patients Receiving Low-Dose Amiodarone*
Ott, M. C., Khoór, A., Leventhal, J. P., Paterick, T. E., & Burger, C. D. (2003) · CHEST Journal · doi:10.1378/chest.123.2.646 · Cited by 148
Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese
Chien, K.-L., Su, T.-C., Hsu, H.-C., Chang, W.-T., Chen, P.-C., Chen, M.-F., & Lee, Y.-T. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.10.045 · Cited by 146
Metadata
- Authors
- Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E.
- Affiliations
- Kaiser Permanente (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-05-09
- Volume
- 285
- Issue
- 18
- Pages
- 2370
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2132505348
- Cited by
- 6,205
- References
- 17
- Citations by year
- 2026: 75 · 2025: 148 · 2024: 193 · 2023: 189 · 2022: 251 · 2021: 263 · 2020: 320 · 2019: 271 · 2018: 323 · 2017: 350 · 2016: 399 · 2015: 437 · 2014: 438 · 2013: 463 · 2012: 424
- FWCI
- 43.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 15478, R01AG015478)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
- Keywords
- prevalence, population projections, older adults, sex differences, racial differences, stroke risk, health maintenance organizations, population aging
- MeSH terms
- Adult, Aged, Aged, 80 and over, Atrial Fibrillation, Cross-Sectional Studies, Female, Forecasting, Humans, Male, Middle Aged, United States, Prevalence, Cost of Illness, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review